Valuable Confidential Information Sample Clauses
The 'Valuable Confidential Information' clause defines and protects information that is considered both confidential and of significant value to a party, such as trade secrets, proprietary data, or sensitive business strategies. This clause typically outlines what types of information are covered, how such information should be handled, and the obligations of the receiving party to maintain its secrecy. Its core practical function is to safeguard critical business assets by ensuring that valuable confidential information is not disclosed or misused, thereby reducing the risk of competitive harm or loss.
Valuable Confidential Information. S▇▇▇▇▇▇ acknowledges that COMPANY has invested substantial time, money and resources in the development and retention of its inventions, confidential information (including marketing and sales strategies, research and development plans, and other kinds of trade secrets), customers, accounts and business partners, and further acknowledges that during the course of his employment with COMPANY, S▇▇▇▇▇▇ had access to COMPANY’s inventions and confidential information (including marketing and sales strategies, research and development plans, and other kinds of trade secrets), and was introduced to existing and prospective customers, accounts and business partners of COMPANY. S▇▇▇▇▇▇ acknowledges and agrees that any and all “goodwill” associated with any existing or prospective customer, account or business partner belongs exclusively to COMPANY, including, but not limited to, any goodwill created as a result of direct or indirect contacts or relationships between S▇▇▇▇▇▇ and any existing or prospective customers, accounts or business partners.
Valuable Confidential Information. GREEN acknowledges that SYNBIOTICS has invested substantial time, money and resources in the development and retention of its inventions, confidential information (including trade secrets), customers, accounts and business partners, and further acknowledges that during the course of his employment with SYNBIOTICS GREEN had access to SYNBIOTICS’ inventions and confidential information (including trade secrets), and was introduced to existing and prospective customers, accounts and business partners of SYNBIOTICS. The parties acknowledge that in connection with GREEN’s provision of consulting services to SYNBIOTICS, he may continue to have access to SYNBIOTICS’ inventions and confidential information (including trade secrets). GREEN acknowledges and agrees that any and all “goodwill” associated with any existing or prospective customer, account or business partner belongs exclusively to SYNBIOTICS, including, but not limited to, any goodwill created as a result of direct or indirect contacts or relationships between GREEN and any existing or prospective customers, accounts or business partners.
Valuable Confidential Information. ▇▇▇▇▇ acknowledges that --------------------------------- SYNBIOTICS has invested substantial time, money and resources in the development and retention of its inventions, confidential information (including trade secrets), customers, accounts and business partners, and further acknowledges that during the course of his employment with the Company ▇▇▇▇▇ had access to the Company's inventions and confidential information (including trade secrets), and was introduced to existing and prospective customers, accounts and business partners of the Company. The parties acknowledge that in connection with ▇▇▇▇▇'▇ provision of consulting services to SYNBIOTICS, he may continue to have access to the Company's inventions and confidential information (including trade secrets). ▇▇▇▇▇ acknowledges and agrees that any and all "goodwill" associated with any existing or prospective customer, account or business partner belongs exclusively to SYNBIOTICS, including, but not limited to, any goodwill created as a result of direct or indirect contacts or relationships between ▇▇▇▇▇ and any existing or prospective customers, accounts or business partners.
Valuable Confidential Information. ROSINACK acknowledges that SYNBIOTICS has invested substantial time, money and resources in the development and retention of its inventions, confidential information (including trade secrets), customers, accounts and business partners, and further acknowledges that during the course of his employment with SYNBIOTICS ROSINACK had access to SYNBIOTICS’ inventions and confidential information (including trade secrets), and was introduced to existing and prospective customers, Table of Contents accounts and business partners of SYNBIOTICS. The parties acknowledge that in connection with ROSINACK’s provision of consulting services to SYNBIOTICS, he may continue to have access to SYNBIOTICS’ inventions and confidential information (including trade secrets). ROSINACK acknowledges and agrees that any and all “goodwill” associated with any existing or prospective customer, account or business partner belongs exclusively to SYNBIOTICS, including, but not limited to, any goodwill created as a result of direct or indirect contacts or relationships between ROSINACK and any existing or prospective customers, accounts or business partners.